Oxycodone is named as a drug or biological intervention in 2 clinical trials in our USA and China trial registers, 2 of which are recruiting. Lead sponsors include Viatris Inc. (1) and Tianjin First Central Hospital (1). Registered phases: Phase 4 and Not applicable. Conditions studied include Healthy, Non-Drug- Dependent, Recreational Opioid Users; Postoperative Pain; Postoperative Ileus.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07813026 | Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users Healthy, Non-Drug- Dependent, Recreational Opioid Users |
Phase 4 | Recruiting |
| NCT07651722 | Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Recovery in Patients Undergoing Major Abdominal Surgery (ClinicalTrials.gov ↗) Postoperative Pain, Postoperative Ileus |
Not applicable | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Healthy, Non-Drug- Dependent, Recreational Opioid Users | 1 |
| Postoperative Pain | 1 |
| Postoperative Ileus | 1 |
| Lead sponsor | Trials |
|---|---|
| Viatris Inc. | 1 |
| Tianjin First Central Hospital | 1 |
| Register | Oxycodone trials |
|---|---|
| Clinical trials in USA | 1 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Oxycodone works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Oxycodone (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.